Загрузка...
Fluorescently-Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study
PURPOSE: Fluorescently labeled epidermal growth factor receptor (EGFR) antibodies can successfully identify microscopic tumors in multiple in vivo models of human cancers with limited toxicity. This study demonstrates the ability of fluorescently labeled anti-EGFR, cetuximab-IRDye800, to localize to...
Сохранить в:
| Опубликовано в: : | J Oral Maxillofac Surg |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541684/ https://ncbi.nlm.nih.gov/pubmed/32554066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joms.2020.05.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|